Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
13.54
+0.28 (2.11%)
Nov 4, 2024, 4:00 PM EST - Market closed
Avalo Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 131 | 7 | 47 | 191 | 4,212 | 18,865 | |
| Market Cap Growth | 175.03% | -84.63% | -75.15% | -95.47% | -77.67% | 14214.17% | |
| Enterprise Value | 51 | -1 | 52 | 153 | 4,180 | 18,877 | |
| Last Close Price | 13.54 | 9.10 | 1209.61 | 4895.96 | 7603.14 | 15523.08 | |
| PE Ratio | - | -0.08 | -1.14 | -2.10 | -3.05 | -19.17 | |
| PS Ratio | 12.15 | 3.79 | 2.63 | 35.37 | 628.78 | 2794.73 | |
| PB Ratio | -6.00 | 1.00 | -4.35 | 8.27 | 171.49 | 898.54 | |
| P/FCF Ratio | -0.40 | -0.24 | -1.77 | -2.69 | -103.74 | -972.63 | |
| P/OCF Ratio | -0.40 | -0.24 | -1.77 | -2.69 | -103.90 | -985.95 | |
| EV/Sales Ratio | 63.03 | -0.46 | 2.87 | 28.36 | 624.03 | 2796.40 | |
| EV/EBITDA Ratio | 3.81 | 0.04 | -1.74 | -1.90 | -91.97 | -1076.51 | |
| EV/EBIT Ratio | 3.78 | 0.04 | -1.73 | -1.86 | -88.39 | -993.84 | |
| EV/FCF Ratio | 2.62 | 0.03 | -1.93 | -2.16 | -102.96 | -973.21 | |
| Debt / Equity Ratio | -0.80 | 0.26 | -1.98 | 1.53 | 0.06 | 0.06 | |
| Debt / FCF Ratio | -0.05 | -0.06 | -0.81 | -0.50 | -0.04 | -0.07 | |
| Asset Turnover | 0.01 | 0.07 | 0.32 | 0.09 | 0.17 | 0.13 | |
| Inventory Turnover | - | - | 896.21 | 2444.83 | 2074.05 | 68.56 | |
| Quick Ratio | 0.97 | 1.64 | 0.68 | 2.99 | 1.53 | 0.39 | |
| Current Ratio | 0.99 | 1.82 | 0.74 | 3.11 | 1.71 | 1.46 | |
| Return on Equity (ROE) | - | - | -684.77% | -354.08% | -282.65% | -77.66% | |
| Return on Assets (ROA) | -20.94% | -53.91% | -32.95% | -82.82% | -74.02% | -22.32% | |
| Return on Capital (ROIC) | -315.18% | -146.88% | -54.11% | -121.58% | -122.42% | -55.00% | |
| Earnings Yield | -27.63% | -432.43% | -87.80% | -44.19% | -1.51% | -0.09% | |
| FCF Yield | -24.48% | -422.75% | -56.58% | -37.19% | -0.96% | -0.10% | |
| Buyback Yield / Dilution | -1461.15% | -608.45% | -8.32% | -41.86% | -28.53% | -64.39% | |
| Total Shareholder Return | -1461.15% | -608.45% | -8.32% | -41.86% | -28.53% | -64.39% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.